REFERENCES

1. Mast EE, Margolis HS, Fiore AE, et al; Advisory Committee on Immunization Practices (ACIP). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005;54(RR-16):1-31. Erratum in: MMWR Morb Mortal Wkly Rep. 2006;55(6):158-159; Erratum in: MMWR Morb Mortal Wkly Rep. 2007;56(48):1267.
2. Post SE, Sodhi NK, Peng CH, Wan K, Pollack HJ. A simulation shows that early treatment of chronic hepatitis B infection can cut deaths and be cost-effective. Health Aff (Millwood). 2011;30(2):340-348.
3. Weinbaum CM, Williams I, Mast EE, et al; Centers for Disease Control. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57(RR08):1-20.
4. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006;28(1):112-125.
5. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases, 12th ed. Atkinson W, Wolfe S, Hamborsky J, eds. Washington, DC: Public Health Foundation; 2012.
6. Immunization Action Coalition. Ask the experts. Hepatitis B.
7. World Health Organization. Hepatitis B. Fact sheet No. 204. Revised August 2008.
8. Lok AS, McMahon BJ. AASLD Practice Guideline Update. Chronic Hepatitis B: Update 2009. Hepatology. 2009;50(3):661-662;1-36.
9. Wasley A, Kruszon-Moran D, Kuhnert W, et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis. 2010;202(2):192-201.
10. Institute of Medicine. Colvin HM, Mitchell AE, eds. Hepatitis and Liver Cancer. A National Strategy for Prevention and Control of Hepatitis B and C. Washington, DC: National Academies Press; 2010.
11. France AM, Bornschlegel K, Lazaroff J, Kennedy J, Balter S. Estimating the prevalence of chronic hepatitis B virus infection--New York City, 2008. J Urban Health. 2012;89(2):373-383.
12. Cohen C, Holmberg SD, McMahon BJ, et al. Is chronic hepatitis B being undertreated in the United States? J Viral Hepat. 2011;18(6):377-383.
13. McGibbon E, Amoroso E, Baptiste-Norville A, et al. Surveillance for chronic hepatitis B virus infection -- New York City, June 2008-November 2009. MMWR Morb Mortal Wkly Rep. 2012;61(01):6-9.
14. Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: immunization of adults. MMWR Recomm Rep. 2006;55(RR16):1-33. Erratum in: MMWR Morb Mortal Wkly Rep. 2007;56(42):1114.
15. Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0 through 18 years--United States, 2012. MMWR Morb Mortal Wkly Rep. 2012;61(5):1-4. Erratum in: MMWR Morb Mortal Wkly Rep. 2012:61(8):147.
16. Centers for Disease Control and Prevention. Recommended adult immunization schedule --- United States, 2012. MMWR Morb Mortal Wkly Rep. 2012;61(04):1-7.
17. Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Hepatology. 2007;46(4):1034-1040.
18. Centers for Disease Control and Prevention. Hepatitis B information for health professionals. Hepatitis B FAQs for health professionals. 2012.
19. Teshale EH. Hepatitis B. In: Brunette G, ed. CDC Health Information for International Travel 2012. New York: Oxford University Press; 2012:chap 3.
20. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2006;44(1 suppl):S6-S9.
21. Chun HM, Roediger MP, Hullsiek KH, et al; Infectious Disease Clinical Research Program HIV Working Group. Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters. J Infect Dis. 2012;205(2):185-193.
22. Sawyer MH, Hoerger TJ, Murphy TV, et al. Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2011;60(50):1709-1711.
23. McMahon BJ, Peters M. Guide for the identification and management of chronic hepatitis B in primary care setting. Alexandria, VA: American Association for the Study of Liver Diseases; 2010.
24. Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010;59(RR12):1-110.
25. del Pozo Balado MM, Leal M, Mendez Lagares G, et al. Increased regulatory T cell counts in HIV-infected nonresponders to hepatitis B virus vaccine. J Infect Dis. 2010;202(3):362-369.
26. World Health Organization. Global alert and response (GAR). Hepatitis D. 2012.
27. McMahon BJ. Implementing evidence-based practice guidelines for the management of chronic hepatitis B virus infection. Am J Med. 2008;121(12 suppl):S45-S52.
28. Tong MJ, Pan CQ, Hann HW, et al. The management of chronic hepatitis B in Asian Americans. Dig Dis Sci. 2011;56(11):3143-3162.
29. Chang ET, Keegan TH, Gomez SL, et al. The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004. Cancer. 2007;109(10):2100-2108.
30. American Cancer Society. Cancer Facts and Figures 2011. Atlanta, GA: American Cancer Society; 2011.
31. New York City Department of Health and Mental Hygiene, Bureau of Vital Statistics. Summary of Vital Statistics 2010, The City of New York. Population and Mortality. December 2011.
32. American Academy of Pediatrics. Hepatitis B. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:337-356.